Electromyography Devices Market Summary
According to Market Research Future analysis, the Electromyography Devices Market Size was valued at USD 1170.0 Million in 2024 & the market is projected to grow from USD 1233.65 Million in 2025 to USD 2095.3 Million by 2035, registering a CAGR of 5.44% during the forecast period 2025–2035. North America led the market with over 52.69% share, generating around USD 650 billion in revenue.
Rising prevalence of neuromuscular disorders and increasing demand for accurate diagnostic solutions are key growth drivers of the electromyography devices market. Technological advancements, including portable and AI-enabled devices, further enhance diagnostic efficiency and support expanding adoption across healthcare and rehabilitation settings.
- According to the World Health Organization (WHO), neurological disorders affect approximately 1 billion people globally, significantly increasing the need for diagnostic tools like electromyography devices for early detection and monitoring.
Key Market Trends & Highlights
The Electromyography Devices Market is experiencing robust growth driven by technological advancements and increasing demand for patient-centric solutions.
- Technological advancements are enhancing the accuracy and efficiency of electromyography devices, thereby improving diagnostic capabilities.
- There is a notable shift towards portable electromyography devices, catering to the growing preference for at-home and on-the-go healthcare solutions.
- The focus on patient-centric solutions is reshaping product development, particularly in the rehabilitation segment, which is witnessing rapid growth.
- Rising prevalence of neuromuscular disorders and increased demand for rehabilitation services are key drivers propelling market expansion in North America and Asia-Pacific.
Market Size & Forecast
| 2024 Market Size | 1170.0 (USD Million) |
| 2035 Market Size | 2095.3 (USD Million) |
| CAGR (2025 - 2035) | 5.44% |
Major Players
Natus Medical Incorporated (US), Medtronic plc (IE), NeuroMetrix Inc. (US), Dantec Dynamics A/S (DK), Cadwell Industries, Inc. (US), Compumedics Limited (AU), MediGus (GB), Zebris Medical GmbH (DE), MyoPowers (US)